The company witnessed a 20.80% growth in the revenue at Rs. 191.58 millions for the quarter ended March 2022 as compared to Rs. 158.59 millions during the year-ago period.The Net Loss for the quarter ended March 2022 is Rs. -113.14 millions as compared to Net Loss of Rs. -69.87 millions of corresponding quarter ended March 2021 Operating profit Margin for the quarter ended March 2022 further decreased to -89.85% as compared to -40.81% of corresponding quarter ended March 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 191.58 158.59 20.80 597.03 537.00 11.18 597.03 537.00 11.18
Other Income 7.93 4.44 78.60 11.56 6.21 86.15 11.56 6.21 86.15
PBIDT -89.85 -40.81 120.17 -328.39 -169.56 93.67 -328.39 -169.56 93.67
Interest 2.80 14.93 -81.25 53.91 62.79 -14.14 53.91 62.79 -14.14
PBDT -92.65 -55.74 66.22 -382.30 -232.35 64.54 -382.30 -232.35 64.54
Depreciation 20.49 14.13 45.01 62.97 51.24 22.89 62.97 51.24 22.89
PBT -113.14 -69.87 61.93 -445.27 -283.59 57.01 -445.27 -283.59 57.01
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -113.14 -69.87 61.93 -445.27 -283.59 57.01 -445.27 -283.59 57.01
Equity 215.61 196.21 9.89 215.61 196.21 9.89 215.61 196.21 9.89
PBIDTM(%) -46.90 -25.73 82.25 -55.00 -31.58 74.20 -55.00 -31.58 74.20

Krebs Biochem.&Inds Share Price

83.40 3.40 (4.25%)
01-Nov-2024 18:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1858.70
Dr. Reddys Lab 1258.55
Cipla 1559.20
Lupin 2198.25
Zydus Lifesciences 1004.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.